Related references
Note: Only part of the references are listed.Long non-coding RNA DUXAP8 promotes the cell proliferation, migration, and invasion of papillary thyroid carcinoma via miR-223-3p mediated regulation of CXCR4
Yan Liu et al.
BIOENGINEERED (2021)
MiR-17-5p promotes cellular proliferation and invasiveness by targeting RUNX3 in gastric cancer
Jin Song et al.
BIOMEDICINE & PHARMACOTHERAPY (2020)
NFAT2 overexpression suppresses the malignancy of hepatocellular carcinoma through inducing Egr2 expression
Jian Wang et al.
BMC CANCER (2020)
The HIF-1A/miR-17-5p/PDCD4 axis contributes to the tumor growth and metastasis of gastric cancer
Jiayu Zhao et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
miR-17-5p knockdown inhibits proliferation, autophagy and promotes apoptosis in thyroid cancer via targeting PTEN
Y. P. Shi et al.
NEOPLASMA (2020)
Antitumor effects of anlotinib in thyroid cancer
Xianhui Ruan et al.
ENDOCRINE-RELATED CANCER (2019)
Long non-coding RNA NR2F1-AS1 promoted proliferation and migration yet suppressed apoptosis of thyroid cancer cells through regulating miRNA-338-3p/CCND1 axis
Feng Guo et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2019)
Long Noncoding RNA MIR17HG Promotes Colorectal Cancer Progression via miR-17-5p
Jie Xu et al.
CANCER RESEARCH (2019)
miR-335-5p targeting ICAM-1 inhibits invasion and metastasis of thyroid cancer cells
Li Luo et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
Controversial Issues in Thyroid Cancer Management
R. Michael Tuttle
JOURNAL OF NUCLEAR MEDICINE (2018)
miR-718 is involved in malignancy of papillary thyroid cancer through repression of PDPK1
Xiuyan Wang et al.
PATHOLOGY RESEARCH AND PRACTICE (2018)
Effect of exosomal miRNA on cancer biology and clinical applications
Zhenqiang Sun et al.
MOLECULAR CANCER (2018)
Cancer Statistics in China, 2015
Wanqing Chen et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2016)
Long noncoding RNA H19 competitively binds miR-17-5p to regulate YES1 expression in thyroid cancer
Lin Liu et al.
FEBS JOURNAL (2016)
Targeting oncomiRNAs and mimicking tumor suppressor miRNAs: New trends in the development of miRNA therapeutic strategies in oncology
Roberto Gambari et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2016)
MicroRNA-613 inhibits cell growth, migration and invasion of papillary thyroid carcinoma by regulating SphK2
Wangwang Qiu et al.
ONCOTARGET (2016)
MicroRNA biogenesis pathways in cancer
Shuibin Lin et al.
NATURE REVIEWS CANCER (2015)
MicroRNAs in Cancer
Gianpiero Di Leva et al.
ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 9 (2014)
Sorafenib in radioactive iodine-refractory well-differentiated metastatic thyroid cancer
Daniel C. McFarland et al.
ONCOTARGETS AND THERAPY (2014)
Anaplastic thyroid cancer: molecular pathogenesis and emerging therapies
Robert C. Smallridge et al.
ENDOCRINE-RELATED CANCER (2009)
Oncogenic role of miR-17-92 cluster in anaplastic thyroid cancer cells
Shu Takakura et al.
CANCER SCIENCE (2008)
EGR2 induces apoptosis in various cancer cell lines by direct transactivation of BNIP3L and BAK
M Unoki et al.
ONCOGENE (2003)
Growth-suppressive effects of BPOZ and EGR2, two genes involved in the PTEN signaling pathway
M Unoki et al.
ONCOGENE (2001)
Differential expression of Fas ligand in Th1 and Th2 cells is regulated by early growth response gene and NF-AT family members
R Dzialo-Hatton et al.
JOURNAL OF IMMUNOLOGY (2001)
Share Paper
